Peripheral Neuropathy

Neurology·MeSH: Peripheral Nervous System Diseases

8 drugs in development·7 companies·2 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
Nucynta ER	COLLEGIUM PHARMACEUTICAL, INC (COLL)
Nucynta ER and Nucynta IR	COLLEGIUM PHARMACEUTICAL, INC (COLL)

Phase 2(4)

Drug	Company
amiket	IMMUNE PHARMACEUTICALS INC (IMNP)
cenplacel-l	Celularity Inc. (CELU)
nyx-2925	Aptinyx Inc. (APTX)
son-080	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)

Phase 1(1)

Drug	Company
ART26.12	ARTELO BIOSCIENCES, INC. (ARTL)

Phase 4(1)

Drug	Company
Palmidrol	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 8 drugs in development for Peripheral Neuropathy across 7 companies.

There are 2 clinical trials targeting Peripheral Neuropathy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.